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Objective: To assess the risk of mother-to-child transmission of HIV-1 in a 
central African population and to study maternal factors associated with perinatal 
transmission. 
Design: Prospective cohort study of infants born to HIV-1 -positive women and 
controls born to HIV-1 -negative women enrolled sequentially in two prenatal clinics 
and one maternity hospital in Brazzaville, Congo. 
Subjects and methods: A total of 11 8 exposed and 208 control infants were followed 
from birth for at least 2 years. Assessment of infection in children and computation of 
transmission rate were made according to the European Economic Community/World 
Health Organization Ghent guidelines (1 992). 
Results: The transmission rate was 40.4% 195% confidence interval (CI), 30.7-50.11. 
Maternal age, parity, history of adverse pregnancy outcome or history of deceased 
children were not associated with transmission. However, independently, women 
whose relationship with their infant's father was less than 1 year, or women who had 
symptoms of HIV-1 during pregnancy had an increased risk of transmission [adjusted 
odds ratios, 11.1 (95% CI, 2.4-50.2) and 10.3 (95% CI, 2.9-37.11, respectively]. 
Conclusion: The transmission rate observed in Congo is in the upper range of the rates 
reported in Africa. The uneven distribution of cofactors for perinatal transmission, 
such as the presence of symptoms of HIV disease during pregnancy, may explain 
some of the variation observed across studies. 
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Introduction 
The most conservative estimates of the World Health 
Organization (WHO) indicated that by the end of 1992, 
more than 5 million women worldwide had been in- 
fected with HIV. About 80% of these women, approxi- 
mately 4 million, were from Af?ica [l]. Although much 
research has been conducted since 1982, when pediatric 
AIDS cases were first reported in North America and 
Europe [2], much uncertainty still exists about the actual 
risks of perinatal transmission and the processes involved 
[3]. 
Published rates of perinatal transmission vary widely 
from 13 to 45% [4-131. Direct comparison of one study 
with another is difficult, however, because of differ- 
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ences in study design, infant HIV infection criteria, 
and methodology for calculating the risk of transmis- 
sion. To render study results comparable, investigators 
involved in HIV-1 perinatal transmission cohort studies 
in Afï-ica, Europe and North America developed a com- 
mon methodology for assessing HIV infection in infants 
and the computation of transmission rates (European 
Economic Community/WHO Ghent, Belgium, 1992) 
[14]. Here we report the results of the Congolese cohort 
study, using this standardized approach. 
Methods 
Pregnant women who had agreed to participate were 
screened for HIV-1 antibodies over two periods, May 
1987 to March 1988, and August to November 1989. 
Afier verbal consent, they were sequentially recruited 
either during their first prenatal visit or at delivery in 
three health centers serving Brazzaville’s eastern districts. 
Women were eligible for inclusion in the cohort with 
their infants if they were living in the districts served by 
the participating centers and had given birth to a live- 
born infant. During the first inclusion period, enrolled 
HIV-1-positive mothers were matched by age, district of 
residence and presumed date of delivery with two HIV- 
1-negative control mothers [15]. During the second in- 
clusion period, HIV-1-positive mothers were matched 
by age and district ofresidence with one HIV-1-negative 
control mother who had delivered on the same or the 
following day. 
Mothers’ sera were tested for antibodies to HIV-1 
by enzyme-linked immunosorbent assay (ELISA; Dia- 
gnostics Pasteur, Marnes-la-Coquette, France). Positive 
ELISA tests were confirmed by Western blot (Du Pont 
de Nemours, Rockville, Maryland, USA). Sera were 
considered positive if they showed antibodies against at 
least two envelope glycoproteins. AU positive results were 
reconfirmed with a subsequent blood sample. 
All women were given their test results and received 
counseling. At inclusion, they had a physical examina- 
tion and a basic interview for demographic data and 
medical and reproductive history. They were then seen 
monthly with their infant by a medical assistant. Ev- 
ery 3 months, the infants received a standardized physi- 
cal examination, always by the same pediatrician, and a 
blood sample was drawn. A nurse maintained continuous 
contact with the fimilies. Women and/or children who 
had not been seen during two subsequent monthly visits 
were actively followed-up. All infants were breastfed. 
All available clinical information and laboratory results 
for mothers and children were reviewed independently 
by two physicians. Women were classified as symp- 
tomatic if they presented with at least one of the WHO 
clinical AIDS definition criteria [16]. Each infant’s HIV 
status was determined at follow-up. A positive serological 
test for HIV antibodies at 15 months was considered 
decisive evidence of HIV infection. Infants who died 
prior to 15 months were classified as infected if they 
either had AIDS according to the WHO case definition 
[16], or met the EEC/WHO Ghent workshop criteria 
for HIV-related death [14]. Infants who died during the 
neonatal period, were lost to follow-up, or could not be 
classified clinically were considered indeterminate. 
The rate of transmission was calculated by the direct 
method based on the case-by-case analysis of the out- 
come for all children born to HIV-1-positive mothers. 
An indirect transmission rate was also calculated based on 
the assumption that, &om birth to 15 months, the mor- 
tality difference between children born to HJV-l-posi- 
tive mothers and controls was due to HIV infection. This 
indirect rate was obtained by combining the mortality 
difference with the proportion of seropositive children 
among those who survived to 15 months [14]. 
The Pearson x 2  test and the Cochran-Armitage test for 
linear trend were used to evaluate associations for cate- 
gorical variables. The probabilities of death at 15 months 
and their 95% confidence intervals (CI) were calculated 
using the Kaplan-Meier and Greenwood methods. Ad- 
justed odds ratios were obtained by the logistic regression 
method. For variables involving more than two levels, 
distinct dichotomous variables corresponding to each le- 
vel were entered into the model. 
Results 
HIV status of children born to HIV-1 -positive 
mothers 
A total of 114 HIV-1-positive women and their 118 
infants were enrolled in the cohort study. Five mothers 
had twins, including one stillborn child. Seventy-three 
children could be tested for antibodies to HIV at 15 
months. Fie-six had seroreverted. Three infants who 
were seronegative at 12 and 15 months later serocon- 
verted. In computing the rate of perinatal transmission, 
these three children were considered uninfected. Seven- 
teen children were seropositive at 15 months. Thirty- 
three children died before 15 months, of whom eight 
had AIDS. Of the remaining 25, 15 were considered 
infected because they met the criteria of HIV-related 
death and 10 could not be classified (Table 1). Finally, of 
the 12 children who could not be followed-up until 15 
months, three were considered uninfected because they 
had seroreverted at 12 months and the HIV status of the 
nine other children remained indeterminate. 
Of the nine liveborn twins of HIV-1-positive mothers, 
two pairs were concordant and infected and one pair was 
concordant and not infected. The HIV status of the three 
others twins, who were premature and died during their 
first week of life, was considered indeterminate. 
Infants at birth and survival 
Infants born to HIV-1-positive mothers were followed 
&om birth along with 208 infants born to 208 HIV- 
... 
I 
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Table I .  Circumstances of death among the 25 children who did not meet the World Health Organization (WHO) AIDS definition criteria. 
Infant identification number 
l f  2f 3: 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18  19 20 21 22 23 24 25 
HIV signs and symptoms* 
Persistent diarrhea b 15 days) 
Oral candidiasist 
Generalized lymphadenopathy 
Failure to thrives 
Recurrent pneumonia 





Age at death (weeks) 
HIV infection status! 
* *  * * * 
* * * *  * *  * * 
* * * '  * *  
* *  * *  * *  * * *  * 
* * * 
* *  * * * * * * *  * * *  * * *  
* *  * * 
* * * * *  
* * 
i 1 i i 1 7 7 i o  1 1  11 15 16 16 16 i a  20 21 25 26 29 33 41 42 47 54 
? ?  ? ? ? ? + + ? ?  + ?  + + + + + + ?  + + + + i +  
*HIV-related signs and symptoms according to the WHO/European Economic Community Ghent workshop [14]. ?Twins; $beyond the neonatal 
period; (in0 weight gain for a period of 3 months or crossing two percentile lines on the growth chart; !assigned based on the presence of 
HIV-related signs and symptoms, and circumstances of death 11 41. ?, indeterminate HIV status; +, HIV-positive. 
Table 2. HIV transmission rate among HIV-l-positive mothers ac- 
cording to maternal characteristics. 
Maternal characteristics n % Transmitting* P 
Age (years) 
c 21 22 31 .a 
21-30 65 46.2 
> 30 12 25.0 
Married 42 28.6 
Not married 57 49.1 
c 1  32 50.0 
1 -5 45 40.0 
>5 22 27.3 
1 26 42.3 
> 1  73 39.7 
Yes 22 45.4 
No 77 39.0 
Yes 20 35.0 
Marital status 
Duration of relationship (years) 
Parity 
History of abortion 
History of miscarriage 
No 79 41 .a 
History of stillbirth 
Yes 3 33.3 
No 96 40.6 
Yes 30 50.0 
No 69 36.2 
None 53 22.6 
At delivery 23 60.9 
Postpahum 23 60.9 
Yes 32 56.3 
History of deceased children 
HIV-1 -related symptoms 
History of transfusion and/or hospitalization since 1980 











was 2.87 kg compared with 3.08 kg for control infants 
(P=0.0004) and 17.9% had a gestational age less than 
38 weeks compared with 7.7%) of the control infants 
(P=0.005). After twins were excluded, lower mean birth 
weight remained the only significant difference between 
the two groups (2.94 versus 3.08 kg; P=O.Ol). 
Probabilities of death in the two groups differed sig- 
nificantly as early as 3 months of age. Survival in in- 
fants born to HIV-positive mothers was 0.91 (95% CI, 
0.85-0.95) at 3 months, 0.74 (95%) CI, 0.66-0.82) at 12 
months and 0.71 (95% CI, 0.61-0.79) at 15 months of 
age. In control infints, it was 0.99 (95% CI, 0.96-1.0) at 
3 months, 0.96 (95% CI, 0.92-0.98) at 12 months and 
0.95 (95% CI, 0.91-0.97) at 15 months. 
Transmission rates 
By the direct method, the estimated transmission rate 
was 40.4% (95% CI, 30.7-50.1). The upper and lower 
estimates of risk of transmission, assuming that all in- 
determinate infants were either infected or uninfected, 
were 33.9% (95% CI, 25.4-42.4) and 50.0% (95% CI, 
41.0-59.0), respectively. The indirect transmission rate 
was 42.7% (95% CI, 32.7-52.7). 
Since twinning only occurred among HIV-l-positive 
mothers and three of the five deaths associated with 
prematurity occurred in twins, we also calculated the 
rates of transmission after excluding twins. Point esti- 
mates were slightly lower 38.7% (95% CI, 28.1-48.0) by 
the direct method with upper and lower limits of 47.2% 
(95% CI, 37.8-56.6) and 32.4% (95% CI, 23.641.2), 
respectively, The indirect estimate was 39.9% (95% CI, 
29.5-50.2). 
*Rate calculated by the direct method (see Methods). 
l-negative control mothers. Infants born to HIV-1- 
positive mothers had a lower birth weight and were 
more likely to be premature. Their mean birth weight 
Maternal characteristics and transmission 
The sociodemographic characteristics, reproductive his- 
tory and clinical status of the 99 mothers whose infant's 
HIV status was known were analyzed for their associa- 
tion with perinatal transmission (Table 2). While age was 
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Table 3. Logistic regression model of maternal characteristics asso- 




OR CI P 
Age (years) 
1 2 1  0.35 0.10-1.17 0.091 
21-30 1 
> 30 0.56 0.11-2.68 0.448 
- - 
Duration of relationship (years) 
<1* 10.99 2.40-50.22 0.03 
1 -5 4.71 1.23-1 8.03 0.026 
1 5  1 
None 1 
Symptoms at delivery 10.33 2.87-37.13 0.001 
Symptoms postpartum 8.29 2.38-28.93 0.001 
*When women‘s marital status was put into the model in piace of 
duration of relationship, it was significantly associated with trans- 
mission [relative risk, 0.38; 95% confidence interval (CI), 0.1 5-0.97; 
P =0.046], and the coefficients were only slightly modified. OR, 
odds ratio. 
not associated with transmission, unmarried women and 
women whose relationship with their infant’s father had 
lasted less than 1 year were more likely to transmit the 
virus to their infants. At delivery, one mother had AIDS 
and 23 had symptoms of HIV infection. Twenty-three 
additional women developed symptoms during the 2- 
year postpartum period. There was a 2.7-fold increase in 
the rate of transmission among women who were or be- 
came symptomatic compared with those who remained 
symptom-fiee. Finally, women who reported at least one 
hospitalization and/or transfusion since 1980 were also 
more likely to transmit the virus to their infants. In the 
multivariate analysis, both the mother’s clinical status and 
her relationship with the infant’s father remained inde- 






Nearly all women in Brazzaville receive prenatal care in 
specialized mother-child clinics and deliver in one of the 
city’s five maternity hospitals. Our study was conducted 
in three of these major facilities. Since most women at- 
tending the clinics agreed to be tested for HIV and to 
participate in the study, it is unlikely that the women 
were selected based on their health status or expectatjon 
of access to care. Therefore, we believe the HIV trans- 
mission rate reported here accurately reflects the rate in 
the Brazzaville population among women of reproduc- 
tive age. 
The transmission rate found in our study is among the 
highest reported in AGica, where rates range fiom 20 
to 45% [8-131. Very similar rates, 39%, were found in 
the first study &om Kinshasa, Zaïre (1986-1987), and 
in a study &om Lusaka, Zambia [9,10]. Comparisons, 
however, must be cautious. In Kinshasa, for example, 
children were defined as infected if they had a positive 
cord blood culture [9], while in Lusaka, they were clas- 
sified as infected if they died with clinical AIDS or were 
seropositive at 2 years of age [lo]. Our results are com- 
parable with those of the Rwandan cohort studies, in 
which study design and criteria for HIV diagnosis were 
the same as in our study [8,12]. Rates in the Rwan- 
dan studies were substantially lower than those found in 
Brazzaville (24.7% in Kigali and 30.0% in Butare). 
Cofactors of perinatal transmission may in part explain 
the differences in the rates observed across studies. For 
example, in the Zambian study and in the first Kin- 
shasa study, where transmission rates were highest, a 
large proportion of women were symptomatic; in Zam- 
bia, 52% had AIDS-related complex (ARC) or general- 
ized lymphadenopathy and in Kinshasa, 17% had AIDS 
[9,10]. In contrast, in a study performed later in Kinshasa 
(1989-1990), the proportion of symptomatic mothers 
was much lower, 1% with AIDS, 7% with ARC, as was 
the transmission rate (26%) [ll]. 
Mortality in infants born to HIV-seropositive mothers 
was much higher than in similar cohort studies carried 
out in Europe and in North America [6,7,17-201. These 
differences may be partly explained by the higher preva- 
lence of nutritional deficiencies and the increased es- 
posure of HIV-infected infants to infectious, parasitic 
and diarrheal diseases in developing countries [17]. This 
mortality rate is consistent with the findings of the first 
perinatal HIV study conducted in a population of simi- 
larly low socioeconomic status in Kinshasa, where infant 
mortality was 28% [9]. Mortality among infants born to 
HIV-1-positive mothers in our study contrasts sharply 
with mortality in the control group. Prematurity and 
low birth weight were more fiequent in infants born to 
HIV-1-seropositive mothers than in control infants but 
most of these differences were attributable to the higher 
rate of twinning in the former group [21]. Moreover, 
infints in both groups received the same follow-up and 
close medical monitoring. Therefore, we believe that 
the excess of mortality in infants. born to HIV-positive 
mothers, especially in singletons, was attributable to HIV 
infection. This is further supported by the similar trans- 
mission rates calculated with both the indirect and direct 
method, even when twins were excluded. 
In our study, three infants, who were seronegative at 
12 and 15 months, later seroconverted. Since no other 
risk factor for infection could be found, breast-feeding 
was the most probable route of infection. Although late 
transmissions were not included in the calculation of the 
transmission rate at 15 months, they may account for a 
significant number of infections in infànts breastfed for 
a long time. Similar cases lof secondary seroconversion 
have been described in Rwanda and Kenya [22,23]. 
We performed a sensitivity analysis to explore the effect 
on the rate of transmission with the assumption that the 
indeterminate infants were all infected or all uninfected. 
The resulting estimated rates were less than 10% above 
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or below the rates calculated by the direct and indi- 
rect methods. Nine indeterminate infants were lost to 
follow-up and 10 died before 15 months of conditions 
that did not meet the criteria of HIV-related death. No 
presumptions were made about their HIV status and it 
is most likely that the proportion of infected to unin- 
fected infants was the same as among the infants with 
a definitive HIV status. Therefore, the median estimates 
with the indirect or direct methods are probably the most 
accurate. 
The association between the presence of HIV-related 
symptoms in women and increased perinatal transmis- 
sion, highly significant in our study, has not been so 
evident in other studies. However, other studies all show 
a similar trend. In our study, women were classified as 
symptomatic with any one sign of the WHO AIDS-case 
definition, while in other studies women were consid- 
ered symptomatic if they had AIDS or ARC [9,10]. 
Assuming that the risk of transmission increases signif- 
icantly in the very early symptomatic stages of HIV in- 
fection, a low threshold clinical criterion may best distin- 
guish between low- and high-risk transmitters. Although 
the trend is still evident, a higher threshold criterion such 
as AIDS could diminish the strength of the association 
between symptoms and transmission. 
Our finding that unmarried women or women whose 
relationship with their infant’s father was brief were more 
at risk of transmitting the virus to their infants was similar 
to the observations made in a Rwandan study in which 
the risk of perinatal transmission increased significantly 
with the number ofsexual partners prior to delivery [12]. 
Several hypotheses may account for this finding. Unmar- 
ried women and women in brief relationships may be 
more likely to be newly infected, with primary infechon 
and seroconversion occurring at the beginning of their 
pregnancies. These women may also have been exposed 
to several viral strains. Infection with an additional strain 
of HIV might behave similarly to primary infection or 
to escape-mutant bursts of replication, resulting in either 
case in a higher risk of fetal transmission [24]. Finally, 
other sexually transmitted diseases (STD) may be more 
prevalent in these women although their role as a cofac- 
tor of perinatal transmission is still unclear. In the study 
fiom Butare, for example, the risk of transmission was 
significantly increased in women reporting a history of 
STD, but it was only weakly increased in women who 
were diagnosed with an STD during pregnancy [12]. 
To date, cohort studies have shown substantial variability 
in the rate of transmission reported in Afiica. Among 
populations, the uneven distribution of maternal factors 
such as those revealed in our study probably accounts for 
some of the variability. Although the mechanisms and 
timing of perinatal transmission are unclear, several clini- 
cal t r ia ls aimed at interrupting perinatal transmission are 
already underway. Since the efticacy of any intervention 
strategy will probably differ depending on the precise 
nature of maternal cofactors and their relationship to the 
timing of transmission, they require further investigation. 
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